Premium Nahrungsergänzungsmittel | artgerecht

Apolipoprotein B – Function, Levels and Risk

Apolipoprotein B is a key transport protein in the blood that carries fats and cholesterol to body cells and is considered a central risk marker for cardiovascular disease.

Regular tips about health Regular tips about health

Things worth knowing about "Apolipoprotein B"

Apolipoprotein B is a key transport protein in the blood that carries fats and cholesterol to body cells and is considered a central risk marker for cardiovascular disease.

What is Apolipoprotein B?

Apolipoprotein B (ApoB) is a large structural protein found on the surface of certain lipoproteins -- the particles responsible for transporting fats (lipids) and cholesterol through the bloodstream. It is an essential component of lipid metabolism and is now recognized as one of the most important biomarkers for assessing cardiovascular risk.

ApoB exists in two main forms: ApoB-100, produced by the liver and found in LDL, VLDL, and IDL particles, and ApoB-48, produced in the small intestine and present in chylomicrons, which transport dietary fats.

Biological Function

The primary role of Apolipoprotein B is to transport lipids such as cholesterol and triglycerides through the bloodstream and deliver them to target cells. ApoB-100 binds to specific LDL receptors on body cells, enabling the uptake of cholesterol into those cells.

ApoB-100 is the sole protein in LDL particles, enabling their recognition by cell receptors.
ApoB-48 is essential for the absorption and transport of dietary fats from the gut.
Each atherogenic lipoprotein particle contains exactly one ApoB molecule -- therefore, the ApoB level directly reflects the total number of these particles in the blood.

Clinical Significance and Cardiovascular Risk

Elevated ApoB levels in the blood are strongly associated with an increased risk of atherosclerosis (hardening of the arteries), heart attack, and stroke. Because ApoB reflects the total number of atherogenic lipoprotein particles, current clinical guidelines consider it a more precise risk marker than LDL cholesterol alone.

In patients with type 2 diabetes, metabolic syndrome, or elevated triglycerides, ApoB may reveal a cardiovascular risk that LDL cholesterol alone would underestimate.

Measurement and Reference Values

Apolipoprotein B is measured via a simple blood test. The sample can be taken fasting or non-fasting. The following reference values serve as general guidance:

Optimal: below 90 mg/dL (below 65 mg/dL for high-risk patients)
Borderline elevated: 90--120 mg/dL
Elevated: above 120 mg/dL

Target values depend on the individual cardiovascular risk profile of the patient and are determined by the treating physician.

Causes of Elevated ApoB Levels

Elevated Apolipoprotein B concentrations can have various causes:

Genetic factors: familial hypercholesterolemia or familial combined hyperlipidemia
Unhealthy diet: high intake of saturated and trans fats
Metabolic disorders: type 2 diabetes, insulin resistance, metabolic syndrome
Hypothyroidism (underactive thyroid)
Kidney diseases such as nephrotic syndrome
Overweight and obesity
Physical inactivity

Treatment and Reduction of Elevated ApoB Levels

Lowering elevated ApoB levels aims to reduce cardiovascular risk. Treatment involves lifestyle modifications and pharmacological therapies:

Lifestyle Changes

Dietary adjustments: reducing saturated fats, increasing fiber and unsaturated fatty acids
Regular physical activity
Weight loss in overweight individuals
Smoking cessation

Pharmacological Therapy

Statins: inhibit cholesterol synthesis in the liver and significantly lower ApoB levels
PCSK9 inhibitors: highly effective antibodies that prevent LDL receptor degradation
Ezetimibe: inhibits cholesterol absorption in the intestine
Fibrates and omega-3 fatty acids: primarily used for elevated triglycerides

ApoB Compared to Other Lipid Markers

Cardiovascular risk has traditionally been assessed using LDL cholesterol, HDL cholesterol, and triglycerides. However, emerging research demonstrates that ApoB can be a superior marker, as it measures the actual number of atherogenic particles rather than just their cholesterol content. In patients with hypertriglyceridemia or small, dense LDL particles, ApoB may provide a more accurate risk assessment.

References

Nordestgaard BG et al. - Fasting Is Not Routinely Required for Determination of a Lipid Profile: Clinical and Laboratory Implications. European Heart Journal, 2016. European Atherosclerosis Society Consensus Panel Statement.
Sniderman AD et al. - A Meta-Analysis of Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, and Apolipoprotein B as Markers of Cardiovascular Risk. Circulation: Cardiovascular Quality and Outcomes, 2011.
Grundy SM et al. - 2018 AHA/ACC Guideline on the Management of Blood Cholesterol. Journal of the American College of Cardiology, 2019.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.